We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Noninvasive Fetal Sex Determination Performed in Just 8 to 10 Weeks of Pregnancy

By LabMedica International staff writers
Posted on 04 Jan 2010
A simple blood test may soon become available that reveals the sex of an unborn baby.

This is the conclusion of researchers, from the University of Amsterdam (The Netherlands), who published their study in the January 2010 issue of the journal Obstetrics and Gynecology. The researchers' goal was to determine the diagnostic accuracy of noninvasive fetal sex determination in maternal plasma. More...
Real-time polymerase chain reaction (PCR) was performed for the SRY gene and multicopy DYS14 marker sequence. Between 2003 and 2009, they tested women who were between 8 and 10 weeks pregnant, examining DNA from their blood samples to predict the sex of the babies in 186 pregnancies. They predicted 105 boys and 81 girls. They were correct every time.

This appears to be good news for parents. Determining the sex of an unborn baby can lead to early detection of specific disorders. Genetic diseases such as hemophilia and Duchenne muscular dystrophy are carried by the X chromosome that usually occurs in males.

Critics, however, warn this is similar to opening Pandora's box as fetal testing evolves. Parents might not always appreciate what they discover. However, critics may be too late to stop the technology from progressing.

The researchers, however, concluded in their study that noninvasive fetal sex determination in maternal plasma is highly effective and clinically applicable.

Related Links:

University of Amsterdam




Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: MG Tech adds STOMmics Stereo-seq spatial multi-omics technology to its potfolio (photo courtesy of STOmics)

MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.